Foley’s Insurance attorneys share a deep industry knowledge and provide legal solutions reflecting and anticipating all aspects of an insurer’s operations. The CLE presentations for this daylong event covered a vast range of topics that touched upon every facet of the insurance industry, such as, cannabis insurance, privacy law developments, reinsurance structures, diversity & inclusion, and much more!
Topics Included:
- Market for Cannabis Insurance
- Michael Kasdin | Partner | Foley
- Robert H. Easton | Chief Compliance Officer, Risk and Insurance Services Segment | Marsh & McLennan Companies, Inc.
- John Kastl | Co-Founder | American Specialty Agriculture LLC
- Privacy Law Developments
- Jen Rathburn | Partner | Foley
- Lionel Weaver | Associate Counsel | Sentry Insurance
- Sabrina Guenther Frigo | Associate General Counsel, Privacy and Data Management | CUNA Mutual Group
- Brian Grill | House Counsel | Acuity Insurance
- What Should I Know About Insuretech?
- JillAllison Opell | Partner | Foley
- Brendan Gallagher | President | Arthur J. Gallagher & Co
- Matt Grossberg | Managing Partner | Ins Strategies
- Reinsurance in M&A – A Perspective in Time
- Kevin Fitzgerald | Partner | Foley
- Morgan Tilleman | Senior Counsel | Foley
- Bobby Bray, Vice President | Insurance-Linked Securities Origination & Structuring | Guy Carpenter Securities
- Diversity and Inclusion
- Sara Madavo | Senior Counsel | Foley
- Jeffrey Gearheart | Senior Vice President, Underwriting | Renaissance Reinsurance
- Ethics
- Will Lopez | Deputy General Counsel | Foley
People
Related Insights
09 May 2024
Events
The FTC Noncompete Rule: Where Do We Go From Here?
On Tuesday, April 23, 2024, the Federal Trade Commission (FTC) voted to finalize a rule abolishing the vast majority of employee noncompetes across the United States.
24 April 2024
Article
FTC Finalizes Rule Against Employee Noncompetes
On April 23, 2024, the Federal Trade Commission voted to finalize a rule abolishing the vast majority of employee noncompetes across the United States.
24 April 2024
Health Care Law Today
FDA Continues to Take Stance That it Will Not Issue CBD Rules
The FDA recently doubled down on its January 26, 2023 position that existing regulatory pathways for foods and dietary supplements are not appropriate to manage the risks of CBD and a new regulatory pathway is needed.